M3, Inc. supplies medical information services for doctors through the Internet. The Company also supports marketing of pharmaceutical companies and medical equipment manufacturers.

[Summary] Consolidated Financial Results For The Fiscal Year Ended March 31, 2025 [Ifrs]

Notice Concerning Differences Between Actual Non-Consolidated Results For The Fy Ended March 31, 2025 And The Previous Fy Ended March 31, 2024

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

M3 Inc (2413 JP)

[Summary] Consolidated Financial Results For The Fiscal Year Ended March 31, 2025 [Ifrs]

Notice Concerning Differences Between Actual Non-Consolidated Results For The Fy Ended March 31, 2025 And The Previous Fy Ended March 31, 2024

Notice Regarding Repurchase Of Own Shares (Under M3'S Articles Of Incorporation Pursuant To Article 459, Paragraph 1 Of The Companies Act)

M3, Inc. Presentation Material

Notice Concerning Determination Of The Terms Of Issuance Of Stock Options (Share Acquisition Rights)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)